Curious to see your top suppliers emissions?
Book a demo for a pilot project
ResMed Inc., a leader in the medical technology sector, is headquartered in the United States and operates extensively across North America, Europe, and Asia-Pacific. Founded in 1989, ResMed has established itself in the precision and optical instruments industry, focusing primarily on innovative solutions for sleep apnoea and chronic obstructive pulmonary disease (COPD).
The company is renowned for its advanced cloud-connected devices, including CPAP machines and digital health solutions, which enhance patient care and streamline clinical workflows. ResMed's commitment to research and development has positioned it as a market leader, with significant achievements in improving patient outcomes and driving industry standards. With a strong emphasis on technology integration, ResMed continues to redefine the landscape of respiratory care and sleep medicine.
57
DitchCarbon score
+28 vs industry average
Resmed’s score of 57 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Resmed?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Medical Device Manufacturing has below-average carbon intensity
Industry performance
0.308
20182025
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Resmed's reported carbon emissions
ResMed, a medical device company headquartered in the US, is actively engaged in climate action, with a focus on reducing its greenhouse gas emissions.
Emissions Data:
- 2025: ResMed reported Scope 1 emissions of approximately 3,957,000 kg CO2e and Scope 2 emissions of approximately 23,573,000 kg CO2e.
- 2024: Scope 1 emissions were approximately 4,236,000 kg CO2e, and Scope 2 emissions were approximately 24,422,000 kg CO2e.
- 2023: Scope 1 emissions totalled approximately 4,453,000 kg CO2e, with Scope 2 emissions at approximately 23,939,000 kg CO2e.
- 2022: Scope 1 emissions were approximately 3,743,000 kg CO2e, and Scope 2 emissions were approximately 21,317,000 kg CO2e.
- 2021: Total emissions were approximately 23,028,000 kg CO2e, comprising Scope 1 emissions of approximately 2,418,000 kg CO2e and Scope 2 emissions of approximately 22,246,000 kg CO2e.
- 2020: Total emissions, covering Scope 1 and 2, were approximately 22,171,000 kg CO2e.
- 2019: Scope 1 and 2 emissions were approximately 19,193,000 kg CO2e.
- 2018: Scope 1 and 2 emissions were approximately 19,353,000 kg CO2e.
- 2017: Total emissions, covering Scope 1 and 2, were approximately 22,290,000 kg CO2e.
ResMed currently discloses Scope 1 and 2 emissions data, with Scope 3 emissions, particularly purchased goods and services, identified as a missing data point.
Climate Commitments and Reduction Targets:
ResMed has set ambitious targets to address its climate impact:
- Net-Zero Ambition: The company has committed to reaching net-zero greenhouse gas emissions across its value chain by FY2050, using FY2022 as a base year.
- Near-Term Targets: ResMed aims to reduce absolute Scope 1 and 2 GHG emissions by 42% by FY2030, also from a FY2022 base year. Additionally, they commit to reducing Scope 3 GHG emissions by 51.6% per MW constructed within the same timeframe.
- Long-Term Targets: By FY2050, ResMed aims for a 90% reduction in Scope 1 and 2 GHG emissions and a 97% reduction in Scope 3 GHG emissions per MW constructed, both from the FY2022 base year.
- Site Emissions Profile: ResMed is developing a site emissions profile and investigating electrification opportunities for its Scope 1 and Scope 2 energy sources, targeting completion by 2025.
- Scope 1 and 2 Reduction to Near Zero: The company previously aimed to reduce its Scope 1 and Scope 2 emissions to near zero by
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Resmed’s Climate Goals (2030 & 2050)
7 goals2050
90% reduction in Scope 1
RES commits to reduce Scope 1 GHG emissions 90% by FY2050 from a FY2022 base year.
Behind target90%
2050
90% reduction in Scope 2
RES commits to reduce Scope 2 GHG emissions 90% by FY2050 from a FY2022 base year.
Behind target90%
2030
42% reduction in Scope 1
RES commits to reduce absolute scope 1 GHG emissions 42% by FY2030 from a FY2022 base year.
Behind target42%
See all 7 climate goals
Sign up to see all goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
FY2030 targetSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Resmed2 months ago
57
Frequently asked questions
Common questions about Resmed’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more